Health Department says the M72/ASO1E TB vaccine is in phase 3 trials in five countries and is preparing for expedited registration and roll-out once approved.
Alimatravir is an investigational once-a-month oral PrEP currently in Phase III trials. It is not yet available in South Africa and would need SAHPRA approval.
Generics, authorised low‑cost versions and regulatory action are reshaping South Africa’s GLP‑1 weight‑loss drug market as patients seek cheaper, safer access.
Police confiscate counterfeit goods worth nearly R78 million in major Limpopo operation More than 162,000 illicit items seized during coordinated law enforcement blitz A large-scale law...
Semaglutide and tirzepatide products are under scrutiny after South Africa’s health regulators warned against the use, prescription and dispensing of recalled iDEXIS medicines. The South African...
South Africa’s booming non-surgical aesthetics sector has created a rapidly expanding underground market where invasive cosmetic procedures are being offered outside regulated healthcare environments, industry sources...
South Africa welcomes breakthrough HIV prevention injection in major health milestone A new chapter in the fight against HIV There are moments in South Africa’s public...
Minister of Agriculture John Steenhuisen met with the acting police minister and AgriSA to discuss rural safety and cross-border stock theftbut farmers say the real crisis is foot-and-mouth disease (FMD),...
Popular stomach remedy recalled: What you need to know about the Citro-Soda warning It’s one of those household staples many South Africans don’t think twice about,...
YAZ PLUS Packaging Error Sparks Legal Scrutiny A packaging error in YAZ PLUS oral contraceptive pills has prompted a possible class action in South Africa, with...